Evidence indicates that the loss of E-cadherin is associated with ovarian cancer metastasis, peritoneal dissemination and poor patient survival [22]–[26], suggesting that E-cadherin functions as a suppressor of tumor invasiveness. This evidence concerns the gene CDH1 and ovarian cancer.